Bharat Bio seeks review of clinical trial mode for Covaxin Vaccine

Covaxin, which is India’s first indigenously developed vaccine, has also been declared to be “safe, immunogenic with no serious side effects” in an article published in Lancet, the prestigious medical journal, on Tuesday.